Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Screaming Eagle Acquisition $750 million IPO
The issuer, a SPAC, offered 75,000,000 units which were listed on Nasdaq
Warner Music Group $351 million block trade
The secondary stock offering consists of 8,562,500 shares
China SCE $150 million senior notes offering
The high-yield notes are due 2024
AgileThought $25 million debut stock offering
The Class A common stock is listed on the Nasdaq Capital Market
Biodesix $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
BTRS Holdings warrant exchange offer
A total of 12,391,408 warrants were exchanged for stock
Valero Energy $1.9 billion cash tender offer
The company purchased certain debt securities
Emerson Electric $3 billion notes offering
The investment-grade notes are due 2028, 2031 and 2051
Legend Biotech $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Dun & Bradstreet $460 million senior notes offering
The high-yield notes are due 2029